These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36275467)
1. The complete organellar genomes of the entheogenic plant Varani AM; Silva SR; Lopes S; Barbosa JBF; Oliveira D; Corrêa MA; Moraes AP; Miranda VFO; Prosdocimi F PeerJ; 2022; 10():e14114. PubMed ID: 36275467 [No Abstract] [Full Text] [Related]
2. The mitogenomic landscape of Banisteriopsis caapi (Malpighiaceae), the sacred liana used for ayahuasca preparation. Chavarro-Mesa E; Almeida JVDA; Silva SR; Lopes SS; Barbosa JBF; Oliveira D; Corrêa MA; Moraes AP; Miranda VFO; Prosdocimi F; Varani AM Genet Mol Biol; 2024; 47(2):e20230301. PubMed ID: 38985012 [TBL] [Abstract][Full Text] [Related]
3. Comparative analyses of Theobroma cacao and T. grandiflorum mitogenomes reveal conserved gene content embedded within complex and plastic structures. de Abreu VAC; Moysés Alves R; Silva SR; Ferro JA; Domingues DS; Miranda VFO; Varani AM Gene; 2023 Jan; 849():146904. PubMed ID: 36150535 [TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay. Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498 [TBL] [Abstract][Full Text] [Related]
5. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. Callaway JC; Brito GS; Neves ES J Psychoactive Drugs; 2005 Jun; 37(2):145-50. PubMed ID: 16149327 [TBL] [Abstract][Full Text] [Related]
6. Ayahuasca for the Treatment of Depression. Palhano-Fontes F; Soares BL; Galvão-Coelho NL; Arcoverde E; Araujo DB Curr Top Behav Neurosci; 2022; 56():113-124. PubMed ID: 34761362 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease. Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895 [TBL] [Abstract][Full Text] [Related]
8. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Hamill J; Hallak J; Dursun SM; Baker G Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418 [TBL] [Abstract][Full Text] [Related]
9. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant. Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968 [TBL] [Abstract][Full Text] [Related]
11. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat. Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017 [TBL] [Abstract][Full Text] [Related]
12. Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Ruffell SGD; Crosland-Wood M; Palmer R; Netzband N; Tsang W; Weiss B; Gandy S; Cowley-Court T; Halman A; McHerron D; Jong A; Kennedy T; White E; Perkins D; Terhune DB; Sarris J PCN Rep; 2023 Dec; 2(4):e146. PubMed ID: 38868739 [TBL] [Abstract][Full Text] [Related]
13. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease. Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588 [TBL] [Abstract][Full Text] [Related]
14. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063 [TBL] [Abstract][Full Text] [Related]
15. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116 [TBL] [Abstract][Full Text] [Related]
16. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage. Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127 [TBL] [Abstract][Full Text] [Related]
18. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015. Heise CW; Brooks DE J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660 [TBL] [Abstract][Full Text] [Related]
19. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026 [TBL] [Abstract][Full Text] [Related]
20. IDENTIFICATION CHALLENGES IN EXAMINATION OF COMMERCIAL PLANT MATERIAL OF PSYCHOTRIA VIRIDIS. Kowalczuk AP; Łozak A; Bachliński R; Duszyński A; Sakowska J; Zjawiony JK Acta Pol Pharm; 2015; 72(4):747-55. PubMed ID: 26647632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]